Skip to main content
. Author manuscript; available in PMC: 2012 Aug 30.
Published in final edited form as: Toxicon. 2010 Jul 24;56(6):1025–1034. doi: 10.1016/j.toxicon.2010.07.007

Fig. 4.

Fig. 4

z-VAD-fmk prevents loss of viability but fails to inhibit PE-mediated inhibition of protein synthesis. S2 cells were treated with the indicated concentrations of PE in the presence or absence of 100μM z-VAD-fmk. As above, cell viability (A) was determined at 48 h using alamarBlue® and protein synthesis inhibition (B) was assessed after 24 h by measuring the amount of {3H}-Leucine incorporated into cellular material. Each point is the mean of at least three determinations. Error bars represent one standard deviation from the mean.